Product Information
FT CHILD IBUPROFEN 100 MG/5 ML is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.0332 per ML under NDC 70677111801. Its NADAC has been published 147 times since Dec 13, 2023.
FDA first approved this application on Nov 23, 2018.
Strength
100 mg/5mL
Manufacturer
Strategic Sourcing Services LLCNDC
70677111801
Classification
Generic
Dosage Form
SUSPENSION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
IBUPROFENApproval Type
Generic (ANDA)
FDA Application
ANDA210602FDA Approved
11/23/2018
On Market Since
8/9/2023
Pharmacological Classes
Price Statistics
The NADAC for FT CHILD IBUPROFEN 100 MG/5 ML has been published 147 times since Dec 13, 2023, and over the history we have for it it has declined 15.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0332 per ML |
|---|---|
| All-time high | $0.0394 (Dec 13, 2023) |
| All-time low | $0.0314 (Jul 17, 2024) |
| 52-week high | $0.0358 |
| 52-week low | $0.0332 |
| Median price | $0.0349 |
| Average price | $0.0350 |
| Largest weekly change | +19.3% (Aug 21, 2024) |
| Weeks tracked | 147 |
| Tracking since | Dec 13, 2023 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 26% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Strategic Sourcing Services LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Ibuprofen Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FT CHILD IBUPROFEN 100 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for FT CHILD IBUPROFEN 100 MG/5 ML, manufactured by Strategic Sourcing Services LLC, is $0.0332 per ML (NDC 70677111801), effective Sep 30, 2026.
How has the price of FT CHILD IBUPROFEN 100 MG/5 ML changed over time?
Over the history we have for it, the NADAC for FT CHILD IBUPROFEN 100 MG/5 ML has declined 15.6%. It has been tracked across 147 weekly CMS publications since Dec 13, 2023.
What are the highest and lowest recorded NADAC prices for FT CHILD IBUPROFEN 100 MG/5 ML?
Since Dec 13, 2023, the NADAC for FT CHILD IBUPROFEN 100 MG/5 ML has ranged from a low of $0.0314 (Jul 17, 2024) to a high of $0.0394 (Dec 13, 2023), with a median of $0.0349 per ML.
Are there cheaper alternatives to FT CHILD IBUPROFEN 100 MG/5 ML?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, IBUPROFEN 100 MG/5 ML SUSP, is $0.0246 per ML — about 26% below FT CHILD IBUPROFEN 100 MG/5 ML.
Who manufactures FT CHILD IBUPROFEN 100 MG/5 ML?
FT CHILD IBUPROFEN 100 MG/5 ML (NDC 70677111801) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.